Indian Patent Office
- All
- News
- Videos
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
Fighting COVID-19: NIPER-Guwahati And Hindustan Antibiotic Ties Up To Manufacture Face-Shields
National Institute of Pharmaceuticals Education and Research-Guwahati, or NIPER-Guwahati, has also filed an Indian design patent and provisional patent at Indian Patent Office in New Delhi on these antimicrobial face-shields.
-
Bajaj Chetak Electric Scooter Design Patented In Europe
Bajaj Auto has always maintained that the Chetak electric scooter is a global product and the company is now one step closer to its European launch. The Pune-based manufacturer has officially registered the Bajaj Chetak design in Europe, according to the documents filed with the European Union Intellectual Property Office (EUIPO). The company had a...
-
Indian Motorcycle Trademarks 'Renegade' Name For New Motorcycle In The US
Polaris-owned Indian Motorcycle has registered a new bike name 'Indian Renegade' in the US. The new name joins the 'Raven' moniker that was recently registered by the biker maker with the US Patents and Trademark office as 'Motorcycles and structural parts therefor'. It's not clear at the moment which Indian motorcycles will be using the new names....
-
Pfizer Gets Patent For Pneumonia Vaccine From Indian Patent Office
Indian patent office grants Pfizer a patent for their pneumonia vaccine Prevnar 13. Though Mdecins Sans Frontires (MSF), a non-profit health group had filed the patent opposition to prevent Pfizer from getting its pneumococcal conjugate vaccine (PCV 13) patented.
-
Government To Communicate With Design Applicants Via Email
The Indian Patent Office has decided that all official communications for registration of designs will be communicated through email or the applicant's digital address.
-
Top American Business Group Seeks Clarity In India's Compulsory License Policy
Top American business advocacy group USIBC has sought transparency, consistency and clarity in the compulsory license policy of the Indian government in a bid to attract investments that are "imperative" for innovation.
-
Indian Patent Office Says No to Software Patents
India's patent office has ruled that only genuine applications claiming a novel hardware component along with software will be eligible for patent protection.
-
Indian Convicted for Selling Counterfeit Cigarettes in US
A 25-year-old Indian national has pleaded guilty to the charges of selling counterfeit cigarettes in the US. Gaurav Joseph Jayaseelan faces several years of imprisonment and a fine of up to USD 250,000 for the charges, the Department of Justice said yesterday.
-
ISB, Deloitte, Nasscom Develop Index for Global In-house Centres in India
Indian School of Business (ISB) and Deloitte Consulting, in association with IT industry body Nasscom, have developed a maturity index for global in-house centres (GICs) in India to help them benchmark their performance relative to industry peers.
-
Drug prices, takeover of domestic firms remain government focus in 2012
A new drug price control policy at long last, restrictions on multinationals taking over domestic firms and India cracking down on foreign firms' patents marked the year 2012 for the country's $22 billion pharmaceutical sector.
-
Pfizer to appeal India decision to revoke cancer drug patent
Pfizer Ltd, the India unit of U.S. drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug Sutent. The company, which will appeal before the Intellectual Property Appellate Board, said on Friday the Indian Patent Office's decision raised concerns over India's commitment to protect intellectual prop...
-
Cancer ruling opens door for cheaper drugs in India
On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug cheaply in India.
-
Tanla Solutions - Tanla is granted patent by the Indian Patent Office - Automated Meter Reading System and method thereof
Tanla Solutions Ltd has informed BSE regarding a Press Release dated August 16, 2010 titled "Tanla is granted patent by the Indian Patent Office - Automated Meter Reading System and method thereof"
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
Fighting COVID-19: NIPER-Guwahati And Hindustan Antibiotic Ties Up To Manufacture Face-Shields
National Institute of Pharmaceuticals Education and Research-Guwahati, or NIPER-Guwahati, has also filed an Indian design patent and provisional patent at Indian Patent Office in New Delhi on these antimicrobial face-shields.
-
Bajaj Chetak Electric Scooter Design Patented In Europe
Bajaj Auto has always maintained that the Chetak electric scooter is a global product and the company is now one step closer to its European launch. The Pune-based manufacturer has officially registered the Bajaj Chetak design in Europe, according to the documents filed with the European Union Intellectual Property Office (EUIPO). The company had a...
-
Indian Motorcycle Trademarks 'Renegade' Name For New Motorcycle In The US
Polaris-owned Indian Motorcycle has registered a new bike name 'Indian Renegade' in the US. The new name joins the 'Raven' moniker that was recently registered by the biker maker with the US Patents and Trademark office as 'Motorcycles and structural parts therefor'. It's not clear at the moment which Indian motorcycles will be using the new names....
-
Pfizer Gets Patent For Pneumonia Vaccine From Indian Patent Office
Indian patent office grants Pfizer a patent for their pneumonia vaccine Prevnar 13. Though Mdecins Sans Frontires (MSF), a non-profit health group had filed the patent opposition to prevent Pfizer from getting its pneumococcal conjugate vaccine (PCV 13) patented.
-
Government To Communicate With Design Applicants Via Email
The Indian Patent Office has decided that all official communications for registration of designs will be communicated through email or the applicant's digital address.
-
Top American Business Group Seeks Clarity In India's Compulsory License Policy
Top American business advocacy group USIBC has sought transparency, consistency and clarity in the compulsory license policy of the Indian government in a bid to attract investments that are "imperative" for innovation.
-
Indian Patent Office Says No to Software Patents
India's patent office has ruled that only genuine applications claiming a novel hardware component along with software will be eligible for patent protection.
-
Indian Convicted for Selling Counterfeit Cigarettes in US
A 25-year-old Indian national has pleaded guilty to the charges of selling counterfeit cigarettes in the US. Gaurav Joseph Jayaseelan faces several years of imprisonment and a fine of up to USD 250,000 for the charges, the Department of Justice said yesterday.
-
ISB, Deloitte, Nasscom Develop Index for Global In-house Centres in India
Indian School of Business (ISB) and Deloitte Consulting, in association with IT industry body Nasscom, have developed a maturity index for global in-house centres (GICs) in India to help them benchmark their performance relative to industry peers.
-
Drug prices, takeover of domestic firms remain government focus in 2012
A new drug price control policy at long last, restrictions on multinationals taking over domestic firms and India cracking down on foreign firms' patents marked the year 2012 for the country's $22 billion pharmaceutical sector.
-
Pfizer to appeal India decision to revoke cancer drug patent
Pfizer Ltd, the India unit of U.S. drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug Sutent. The company, which will appeal before the Intellectual Property Appellate Board, said on Friday the Indian Patent Office's decision raised concerns over India's commitment to protect intellectual prop...
-
Cancer ruling opens door for cheaper drugs in India
On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug cheaply in India.
-
Tanla Solutions - Tanla is granted patent by the Indian Patent Office - Automated Meter Reading System and method thereof
Tanla Solutions Ltd has informed BSE regarding a Press Release dated August 16, 2010 titled "Tanla is granted patent by the Indian Patent Office - Automated Meter Reading System and method thereof"
